Onesource Specialty Pharma: Intimation of change in designation of Dr. Claudio Albrecht from Independent director to Non-Executive…
Onesource Specialty Pharma (ONESOURCE) filed a disclosure titled "Intimation of change in designation of Dr. Claudio Albrecht from Independent director to Non-Executive Non-Independent Director of the Company". The company is valued at about ₹17,107 crore.
What happened
Onesource Specialty Pharma (ONESOURCE) filed a disclosure with the exchanges on 27 October 2026 at 10:13 AM titled "Intimation of change in designation of Dr. Claudio Albrecht from Independent director to Non-Executive Non-Independent Director of the Company".
Company snapshot
Onesource Specialty Pharma is a small-cap company in the Healthcare sector, with a market value of about ₹17,107 crore.
The stock last traded at ₹1,492.2, against a 52-week range of ₹1,057–₹1,925 (22.5% below the high).
Before this filing the shares had moved −16.0% over the month and −19.3% over three months. Average daily turnover over the last 20 sessions was about ₹31.29 crore.
Promoters held 30.48% at the end of Q1 FY27; 37.23% of promoter shares were pledged. Foreign institutions owned 19.19% and domestic institutions 23.38%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 327 | -0.2 | -0.02 |
| Q2 FY26 | 376 | 10.5 | 0.92 |
| Q3 FY26 | 290 | -88.7 | -7.74 |
| Q4 FY26 | 428 | 4.6 | 0.4 |
| Q1 FY27 | 449 | 25 | 2.18 |
What history shows
This is not the company's first management change disclosure: BCEIE has 3 earlier filings of this kind on record since May 2026.
After those filings, the stock gained 2.9% on average the next trading day and was down 7.5% on average after five days (3 filings with price data).
Across 108 similar disclosures by other Healthcare companies, shares moved +0.8% on average the next day and +1.7% over five days; 47% of them rose the next day.
Market-wide, 4,000 management change filings with an impact score of 50 or more saw an average next-day move of −0.1%, with 44% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 23 Sept 2026 | Change in Auditors of the company. | +0.4% | — |
| 27 Jul 2026 | Management change | +3.6% | −9.4% |
| 24 Jul 2026 | Management change | +4.7% | −5.6% |
What to watch
- The appointment of a successor and any change in strategy or guidance.
- 27 October 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
- OneSource Specialty Pharma Limited Estimates – NSE:ONESOURCE
- Onesource Specialty Pharma - JSW Steel among 5 stocks showing the White Marubozu pattern
- Onesource Specialty Pharma (ONESOURCE.NS) Ticks Higher: Price Holds ₹1,376.2 With Support at ₹1,307.39 - Gap Up Stocks
- OneSource Specialty Pharma Ltd Faces Bearish Momentum Amid Technical Downgrade
- OneSource Specialty Pharma share price jumps 7.4% to ₹1,500 after Q2 profit surges, EBITDA margin expands to over 30%
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.